# Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis

> **NCT01830699** · NA · COMPLETED · sponsor: **Keesler Air Force Base Medical Center** · enrollment: 33 (actual)

## Conditions studied

- Subacromial Bursitis

## Interventions

- **DRUG:** Rilonacept
- **DRUG:** Corticosteroid

## Key facts

- **NCT ID:** NCT01830699
- **Lead sponsor:** Keesler Air Force Base Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2014-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01830699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01830699, "Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01830699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*